Note! Please note that this article is currently in the "Article in Press" stage and is not the final "Version of record". While it has been accepted, copy-edited, and formatted, however, it is still undergoing proofreading and corrections by the authors. Therefore, the text may still change before the final publication. Although "Articles in Press" may not have all bibliographic details available, the DOI and the year of online publication can still be used to cite them. The article title, DOI, publication year, and author(s) should all be included in the citation format. Once the final "Version of record" becomes available the "Article in Press" will be replaced by that.
Abstract
Background: Creutzfeldt-Jakob disease (CJD) is a fatal degenerative brain disease characterized by rapidly progressive dementia. Sporadic CJD (sCJD) is the best-known and most common subtype. Because the disease is uncommon and has highly diverse presenting symptoms, early diagnosis is challenging. We herein report a case of probable sCJD diagnosed at a very early stage.
Case Presentation: A 61-year-old female patient had mild attention and memory problems for a few months that were noticed by her husband but did not bother her and did not affect her daily life activities. The first brain magnetic resonance imaging (MRI) at another hospital was normal, lacking diffusion-weighted imaging (DWI). Although the newly taken brain MRI without DWI was normal, the patient's husband brought his patient to our outpatient clinic because he continued to think that there was a difference in his wife's attention and memory. A neurological examination of the patient revealed almost normal findings. The neuropsychiatric evaluation of the patient was consistent with mild cognitive impairment. The patient's electroencephalography taken upon admission had no characteristic findings for CJD but showed generalized epileptiform activity. Therefore, the patient was hospitalized, and a second brain MRI, including DWI sequences, was performed. DWI displayed bilateral asymmetrical typical patterns of restricted diffusion. Cerebrospinal fluid 14-3-3 was positive, and total-tau was highly elevated. She had a diagnosis of probable sCJD at an early stage. Later, the patient developed progressive dementia, ataxia, seizures, and extrapyramidal symptoms, followed by mutism, and died. Conclusion: Although there is no cure for CJD today, early diagnosis is essential, mainly because of its potential infectivity and for future planning. Diagnosing sCJD in its early stages is difficult. However, taking into account the observations of not only the patient's history but also their longterm partners in cognitive evaluations will be helpful in making an early and accurate diagnosis.[1]
Zerr I. Laboratory diagnosis of Creutzfeldt–Jakob disease. N Engl J Med 2022; 386(14): 1345-50.
[http://dx.doi.org/10.1056/NEJMra2119323] [PMID: 35388668]
[http://dx.doi.org/10.1056/NEJMra2119323] [PMID: 35388668]
[2]
Hermann P, Appleby B, Brandel JP, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol 2021; 20(3): 235-46.
[http://dx.doi.org/10.1016/S1474-4422(20)30477-4] [PMID: 33609480]
[http://dx.doi.org/10.1016/S1474-4422(20)30477-4] [PMID: 33609480]
[3]
Watson N, Brandel JP, Green A, et al. The importance of ongoing international surveillance for Creutzfeldt–Jakob disease. Nat Rev Neurol 2021; 17(6): 362-79.
[http://dx.doi.org/10.1038/s41582-021-00488-7] [PMID: 33972773]
[http://dx.doi.org/10.1038/s41582-021-00488-7] [PMID: 33972773]
[4]
Denouel A, Brandel JP, Seilhean D, Laplanche JL, Elbaz A, Haik S. The role of environmental factors on sporadic Creutzfeldt-Jakob disease mortality: evidence from an age-period-cohort analysis. Eur J Epidemiol 2023; 38(7): 757-64.
[http://dx.doi.org/10.1007/s10654-023-01004-5] [PMID: 37191829]
[http://dx.doi.org/10.1007/s10654-023-01004-5] [PMID: 37191829]
[5]
Hermann P, Haller P, Goebel S, et al. Total and phosphorylated cerebrospinal fluid tau in the differential diagnosis of sporadic creutzfeldt-jakob disease and rapidly progressive Alzheimer’s Disease. Viruses 2022; 14(2): 276.
[http://dx.doi.org/10.3390/v14020276] [PMID: 35215868]
[http://dx.doi.org/10.3390/v14020276] [PMID: 35215868]
[6]
Uttley L, Carroll C, Wong R, Hilton DA, Stevenson M. Creutzfeldt-Jakob disease: A systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis 2020; 20(1): e2-e10.
[http://dx.doi.org/10.1016/S1473-3099(19)30615-2] [PMID: 31876504]
[http://dx.doi.org/10.1016/S1473-3099(19)30615-2] [PMID: 31876504]
[7]
Watson N, Hermann P, Ladogana A, et al. Validation of revised international creutzfeldt-jakob disease surveillance network diagnostic criteria for sporadic creutzfeldt-jakob disease. JAMA Netw Open 2022; 5(1): e2146319.
[http://dx.doi.org/10.1001/jamanetworkopen.2021.46319] [PMID: 35099544]
[http://dx.doi.org/10.1001/jamanetworkopen.2021.46319] [PMID: 35099544]
[8]
Hermann P, Zerr I. Rapidly progressive dementias — aetiologies, diagnosis and management. Nat Rev Neurol 2022; 18(6): 363-76.
[http://dx.doi.org/10.1038/s41582-022-00659-0] [PMID: 35508635]
[http://dx.doi.org/10.1038/s41582-022-00659-0] [PMID: 35508635]
[9]
Hermann P, Laux M, Glatzel M, et al. Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance. Neurology 2018; 91(4): e331-8.
[http://dx.doi.org/10.1212/WNL.0000000000005860] [PMID: 29934424]
[http://dx.doi.org/10.1212/WNL.0000000000005860] [PMID: 29934424]
[10]
Llorens F, Rübsamen N, Hermann P, et al. A prognostic model for overall survival in sporadic Creutzfeldt-Jakob disease. Alzheimers Dement 2020; 16(10): 1438-47.
[http://dx.doi.org/10.1002/alz.12133] [PMID: 32614136]
[http://dx.doi.org/10.1002/alz.12133] [PMID: 32614136]
[11]
Tokumaru AM, Saito Y, Murayma S. Diffusion-weighted imaging is key to diagnosing specific diseases. Magn Reson Imaging Clin N Am 2021; 29(2): 163-83.
[http://dx.doi.org/10.1016/j.mric.2021.02.001] [PMID: 33902901]
[http://dx.doi.org/10.1016/j.mric.2021.02.001] [PMID: 33902901]
[12]
Gräfe D, Päts A, Merkenschlager A, et al. STEAM-DWI as a robust alternative to EPI-DWI: Evaluation in pediatric brain MRI. PLoS One 2022; 17(5): e0268523.
[http://dx.doi.org/10.1371/journal.pone.0268523] [PMID: 35584126]
[http://dx.doi.org/10.1371/journal.pone.0268523] [PMID: 35584126]
[13]
Morris H, Kaplan PW, Kane N. Electroencephalography in encephalopathy and encephalitis. Pract Neurol 2023. (Epub ahead of print)
[PMID: 38050141]
[PMID: 38050141]